Coalescent pleural malignant mesothelioma and adenocarcinoma of the lung, involving only minor asbestos exposure

Pathology International

Volumn 58, Issue 7, 2008, Pages 451-455

  Tsuzuki, Toyonori ^a   Ninomiya, Hironori ^b   Natori, Yuji ^c   Ishikawa, Yuichi ^b  

^a NAGOYA DAINI RED CROSS HOSPITAL   (Japan)

^b CANCER INSTITUTE   (Japan)

^c Hirano Kameido Himawari Clinic   (Japan)

Author keywords

Immunohistochemistry; Pleural malignant mesothelioma; Pulmonary adenocarcinoma

Indexed keywords

ASBESTOS; CALRETININ; CARCINOEMBRYONIC ANTIGEN; MONOCLONAL ANTIBODY D2-40; THYROID TRANSCRIPTION FACTOR 1; TUMOR MARKER; WT1 PROTEIN;

ADULT; ARTICLE; BRONCHUS BIOPSY; CASE REPORT; CLINICAL FEATURE; ENVIRONMENTAL EXPOSURE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG LESION; LUNG LOBECTOMY; MALE; MALIGNANT MESOTHELIOMA; PRIORITY JOURNAL;

ADENOCARCINOMA; ASBESTOS; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MESOTHELIOMA; MIDDLE AGED; NEOPLASMS, MULTIPLE PRIMARY; PLEURAL NEOPLASMS;

EID: 44949165419     PISSN: 13205463     EISSN: 14401827     Source Type: Journal    
DOI: 10.1111/j.1440-1827.2008.02253.x     Document Type: Article

References (17)

1. Allen TC, Moran C. Synchronous pulmonary carcinoma and pleural diffuse malignant mesothelioma. Arch Pathol Lab Med 2006 130 : 721 4.
2. Attanoos RL, Thomas DH, Gibbs AR. Synchronous diffuse malignant mesothelioma and carcinomas in asbestos-exposed individuals. Histopathology 2003 43 : 387 92.
3. Cagle PT, Wessels R, Greenberg D. Concurrent mesothelioma and adenocarcinoma of the lung in a patient with asbestosis. Mod Pathol 1993 6 : 438 41.
4. French CA, Sugarbaker DJ, Corson JM. Synchronous pleural mesothelioma and primary lung carcinoma. Mod Pathol 1999 12 : 183A.
5. Lee AH, Soomro IN. Collision tumour of the pleura composed of small cell carcinoma and malignant mesothelioma. Histopathology 2004 45 : 305 6.
6. Suzuki Y. Correspondence: Concurrent mesothelioma and adenocarcinoma of the lung in a patient with asbestosis. Mod Pathol 1994 7 : 888 9.
7. Okumura T, Okada M, Tsuji M et al. Mesothelioma with lung cancer complicating asbestosis. Acta Pathol Jpn 1980 30 : 579 90.
8. Kouyama N. Analysis of asbestos exposure in malignant mesothelioma. Pathol Clin Med (Byori To Rinsho) 2004 22 : 667 74 (in Japanese).
9. Tossavainen A. Consensus report. Asbestos, asbestosis, and cancer: The Helsinki Criteria for diagnosis and attribution. Scand J Work Environ Health 1997 23 : P311 16.
10. Ishiwata H, Itoh K, Miura H, Natori Y, Kimura Y. Microscopic calculation of asbestos body and fibers in biomaterials at Yokosuka Kyosai Hospital. J Clin Lab Inst Reag 2006 29 : 181 94 (in Japanese).
11. Roggli VL, Oury TD, Sporn TA. Pathology of Asbestos-Associated Diseases, 2nd edn. New York : Springer-Verlag, 1992.
12. Yaziji H, Battifora H, Barry TS et al. Evaluation of 12 antibodies for distinguishing epithelioid mesothelioma from adenocarcinoma: Identification of a three-antibody immunohistochemical panel with maximal sensitivity and specificity. Mod Pathol 2006 19 : 514 23.
13. Miettinen M, Sarlomo-Rikala M. Expression of calretinin, thrombomodulin, keratin 5, and mesothelin in lung carcinomas of different types: An immunohistochemical analysis of 596 tumors in comparison with epithelioid mesotheliomas of the pleura. Am J Surg Pathol 2003 27 : 150 58.
14. Ordonez NG. The immunohistochemical diagnosis of mesothelioma: A comparative study of epithelioid mesothelioma and lung adenocarcinoma. Am J Surg Pathol 2003 27 : 1031 51.
15. Ordonez NG. Immunohistochemical diagnosis of epithelioid mesothelioma: An update. Arch Pathol Lab Med 2005 129 : 1407 14.
16. Boutin C, Rey F, Gouvernet J et al. Thoracoscopy in pleural malignant mesothelioma: A prospective study of 188 consecutive patients. Part 2: Prognosis and staging. Cancer 1993 72 : 394 404.
17. Gibbs A, Attanoos RL, Churg A et al. The 'Helsinki criteria' for attribution of lung cancer to asbestos exposure: How robust are the criteria? Arch Pathol Lab Med 2007 131 : 181 3.